Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Nishikawa

Showing results (41-50 of 197) with videos related to

Pageof 20
Sort By:
International Immunology|January 3, 2018
Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanomaYoshiko Takeuchi, Atsushi Tanemura, Yasuko Tada, et al.
STAR Protocols|July 19, 2022
Isolation of tumor-infiltrating lymphocytes from preserved human tumor tissue specimens for downstream characterizationTamiyo Kobayashi, Shogo Kumagai, Rieko Doi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination TherapiesMeenal Datta, Lisa M Coussens, Hiroyoshi Nishikawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccinationHiroyoshi Nishikawa, Feng Qian, Takemasa Tsuji, et al.
Biochemical and Biophysical Research Communications|May 27, 2026
Satb1 enforces CD4<sup>+</sup> effector T cell lineage stability by repressing Foxp3 via DNA methylationWooseok Seo, Chengcheng Zou, Krutula Nair, et al.
Cancer Science|May 13, 2009
Glucocorticoid-induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen-specific CD8+ T cells with tumor regressionNaoko Imai, Hiroaki Ikeda, Isao Tawara, et al.
European Journal of Immunology|April 17, 2010
Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesisDaiko Wakita, Kentaro Sumida, Yoichiro Iwakura, et al.
International Immunology|July 31, 2020
Newly emerged immunogenic neoantigens in established tumors enable hosts to regain immunosurveillance in a T-cell-dependent mannerTomoaki Muramatsu, Takuro Noguchi, Daisuke Sugiyama, et al.
Internal Medicine (Tokyo, Japan)|July 5, 2006
De novo CD5-positive diffuse large B-cell lymphoma of the temporal bone presenting with an external auditory canal tumorShoko Ogawa, Isao Tawara, Satoshi Ueno, et al.
The Journal of Investigative Dermatology|January 27, 2019
Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti-PD-1 TherapyTakashi Inozume, Tomonori Yaguchi, Ryo Ariyasu, et al.
Pageof 20

Showing results (41-50 of 197) with videos related to

Sort By:
Pageof 20
International Immunology|January 3, 2018
Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanomaYoshiko Takeuchi, Atsushi Tanemura, Yasuko Tada, et al.
STAR Protocols|July 19, 2022
Isolation of tumor-infiltrating lymphocytes from preserved human tumor tissue specimens for downstream characterizationTamiyo Kobayashi, Shogo Kumagai, Rieko Doi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination TherapiesMeenal Datta, Lisa M Coussens, Hiroyoshi Nishikawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccinationHiroyoshi Nishikawa, Feng Qian, Takemasa Tsuji, et al.
Biochemical and Biophysical Research Communications|May 27, 2026
Satb1 enforces CD4<sup>+</sup> effector T cell lineage stability by repressing Foxp3 via DNA methylationWooseok Seo, Chengcheng Zou, Krutula Nair, et al.
Cancer Science|May 13, 2009
Glucocorticoid-induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen-specific CD8+ T cells with tumor regressionNaoko Imai, Hiroaki Ikeda, Isao Tawara, et al.
European Journal of Immunology|April 17, 2010
Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesisDaiko Wakita, Kentaro Sumida, Yoichiro Iwakura, et al.
International Immunology|July 31, 2020
Newly emerged immunogenic neoantigens in established tumors enable hosts to regain immunosurveillance in a T-cell-dependent mannerTomoaki Muramatsu, Takuro Noguchi, Daisuke Sugiyama, et al.
Internal Medicine (Tokyo, Japan)|July 5, 2006
De novo CD5-positive diffuse large B-cell lymphoma of the temporal bone presenting with an external auditory canal tumorShoko Ogawa, Isao Tawara, Satoshi Ueno, et al.
The Journal of Investigative Dermatology|January 27, 2019
Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti-PD-1 TherapyTakashi Inozume, Tomonori Yaguchi, Ryo Ariyasu, et al.
Pageof 20